현재가
Meihua International Medical Technologies Co., Ltd. is engaged in the manufacturing and marketing of medical consumables in the People's Republic of China.
e.g. Promoter holding
Loading chart...
애널리스트 컨센서스 기준 EPS 및 매출 전망.
해당 기업의 실적 전망 데이터가 없습니다.
| S.No. | Name | Symbol | Market Cap | P/E | P/B | Profit Margin | Op. Margin | ROE | Rev. Growth |
|---|---|---|---|---|---|---|---|---|---|
| 1. | EEmbecta Co... | EMBC | $366.02M | 4.40 | 2.61 | 8.59% | 23.30% | — | -8.10% |
| 2. | PPro-Dex In... | PDEX | $210.11M | 18.09 | 4.25 | 15.10% | 16.80% | 26.50% | 11.00% |
| 3. | UUtah Medic... | UTMD | $204.92M | 21.55 | 1.66 | 30.50% | 34.30% | 8.81% | -12.10% |
| 4. | NEnvista Ho... | NVST | $3.93B | 6.36 | 1.27 | 22.00% | 10.60% | 20.50% | 3.20% |
| 5. | NAnbio Biot... | NNNN | $167.66M | 25.47 | 5.68 | 74.10% | 66.70% | 27.10% | 73.90% |
연결 기준 (백만 단위) / 별도 보기 가능
| Quarter (M) | Sep 23 | Dec 23 | Mar 24 | Jun 24 | Sep 24 | Dec 24 | Mar 25 | Jun 25 |
|---|---|---|---|---|---|---|---|---|
Revenue | 24.45 | 48.91 | 22.67 | 45.34 | 25.78 | 51.57 | 18.99 | 37.98 |
COGS | 16.47 | 32.93 | 15.1 | 30.21 | 16.75 | 33.54 | 12.68 | 25.37 |
Gross Profit | 7.99 | 15.97 | 7.57 | 15.14 | 9.04 | 18.03 | 6.31 | 12.61 |
Gross Profit % | 32.66% | 32.66% | 33.38% | 33.38% | 35.04% | 34.96% | 33.21% | 33.21% |
| 5.21 | 10.41 | 4.62 | 9.24 | 4.83 | 9.61 | 4.69 | 9.37 | |
EBIT | 2.79 | 5.58 | 2.95 | 5.89 | 4.21 | 8.42 | 1.62 | 3.24 |
OPM % | 11.41% | 11.41% | 12.99% | 12.99% | 16.33% | 16.33% | 8.53% | 8.53% |
Non-Operating Income | 0.19 | 0.37 | -0 | -0.01 | -0.34 | -0.68 | 0.28 | 0.56 |
PBT | 2.98 | 5.95 | 2.94 | 5.89 | 3.87 | 7.74 | 1.9 | 3.8 |
Income Tax | 0.7 | 1.39 | 0.59 | 1.18 | 0.81 | 1.61 | 0.33 | 0.66 |
Tax Rate % | 23.41% | 23.41% | 19.97% | 19.97% | 20.85% | 20.85% | 17.3% | 17.3% |
Net Income | 2.28 | 4.56 | 2.36 | 4.72 | 3.06 | 6.13 | 1.57 | 3.15 |
NPM % | 9.33% | 9.33% | 10.4% | 10.4% | 11.88% | 11.88% | 8.28% | 8.28% |
연결 기준 (백만 단위) / 별도 보기 가능
| Period (M) | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|---|---|
Revenue | 75.71 | 79.63 | 89.06 | 104.04 | 103.35 | 97.1 | 96.91 |
COGS | 43.82 | 47.42 | 51.9 | 64.23 | 65.25 | 64 | 63.61 |
Gross Profit | 31.89 | 32.21 | 37.16 | 39.81 | 38.1 | 33.09 | 33.3 |
Gross Profit % | 42.12% | 40.45% | 41.72% | 38.26% | 36.86% | 34.08% | 34.36% |
| 13.1 | 12.82 | 13.69 | 14.5 | 22.54 | 18.42 | 18.99 | |
EBIT | 19.18 | 19.39 | 23.47 | 25.3 | 10.8 | 14.67 | 14.31 |
OPM % | 25.33% | 24.35% | 26.35% | 24.32% | 10.45% | 15.11% | 14.77% |
Non-Operating Income | -0.47 | -0.14 | 0.27 | -0.03 | 0.09 | 0.37 | -0.69 |
PBT | 18.71 | 19.25 | 23.73 | 25.27 | 10.89 | 15.05 | 13.63 |
Income Tax | 3.23 | 3.82 | 4.69 | 5.28 | 4.71 | 3.46 | 2.79 |
Tax Rate % | 17.28% | 19.84% | 19.75% | 20.89% | 43.28% | 22.98% | 20.47% |
Net Income | 15.48 | 15.43 | 19.05 | 19.99 | 6.24 | 11.63 | 10.84 |
NPM % | 20.44% | 19.38% | 21.38% | 19.22% | 6.04% | 11.97% | 11.19% |
연결 기준 (백만 단위) / 별도 보기 가능
| Period (M) | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|---|---|
| 14.8 | 16.03 | 7.19 | 8.15 | 26.74 | 16.93 | 15.96 | |
| 0 | 0.86 | 0.92 | 0.94 | 6.67 | 6.13 | 22.39 | |
| 3.7 | 3.4 | 7.1 | 7.48 | 0 | 0 | 0 | |
| 35.17 | 36.55 | 60.38 | 89.13 | 108.58 | 115.31 | 127.48 | |
| 8.75 | 16.37 | 30.46 | 31.16 | 21.59 | 33.55 | 20.41 | |
Total Assets | 62.42 | 73.2 | 106.05 | 136.86 | 163.58 | 171.92 | 186.24 |
| 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
| 44.45 | 59.65 | 84.73 | 106.8 | 138.11 | 146.32 | 158.96 | |
| 2.04 | 2.59 | 3.22 | 5.18 | 6.81 | 7.33 | 7.95 | |
| 15.92 | 9.92 | 16.35 | 24.87 | 16.95 | 16.66 | 18.07 | |
| 0 | 1.05 | 1.75 | 0 | 1.13 | 1.08 | 1.24 | |
Total Liabilities | 62.42 | 73.2 | 106.05 | 136.86 | 163.02 | 171.41 | 186.24 |
연결 기준 (백만 단위) / 별도 보기 가능
| Period (M) | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|---|---|
| 11.82 | 9.31 | 5.33 | -0.05 | -9.16 | 2.28 | 14.64 | |
| -7.57 | -8.9 | -16.09 | -0.83 | -8.62 | -12.46 | -20.42 | |
| -4.2 | 0.92 | 1.71 | 1.86 | 37.25 | 0.71 | 6.21 | |
Net CFNet Cash Flow | 0.04 | 1.33 | -9.06 | 0.97 | 19.46 | -9.48 | 0.43 |
FCFFree Cash Flow | 11.8 | 0.36 | -10.79 | -0.9 | -11.86 | -2.41 | 14.5 |
Financial ratios and valuation metrics by fiscal year.
| Period | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 |
|---|---|---|---|---|---|---|---|
| - | 29.6% | 26.4% | 20.9% | 5.1% | 8.2% | 7.1% | |
| 0.05 | 0.04 | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | |
| 2.78 | 3.88 | 3.17 | 3.24 | 5.60 | 5.27 | 5.26 | |
| - | 1.17 | 0.99 | 0.86 | 0.69 | 0.58 | 0.54 | |
Cash Conversion | 0.76 | 0.60 | 0.28 | -0.00 | -1.47 | 0.20 | 1.35 |
Payout Ratio | - | - | - | - | - | - | - |
| - | 5.2% | 11.8% | 16.8% | -0.7% | -6.0% | -0.2% | |
| - | - | - | - | - | - | - | |
| - | - | - | - | - | - | - | |
| 4.00 | 5.00 | 5.00 | 4.00 | 2.00 | 5.00 | 5.00 | |
| - | -1.60 | -1.16 | -1.46 | -2.24 | -1.89 | -2.44 | |
| 80.00 | 80.00 | 70.00 | 60.00 | 40.00 | 50.00 | 75.00 | |
| 0.2% | 0.2% | 0.2% | 0.2% | 0.1% | 0.1% | 0.1% |
Note: These ratios and scores are calculated using publicly available financial data and may differ from other sources. Users are advised to verify calculations independently using SEC filings or other official sources before making investment decisions.
Meihua International Medical Technologies Co Ltd의 주주 구성 (SEC 공시 기준)
Schedule 13D / 13G filers (5%+), plus stakes Meihua International Medical Technologies Co Ltd holds in others · open a holder to see each filing
| Holder | Type | Based in | Shares | % of class | Latest filing |
|---|---|---|---|---|---|
| Investment adviser | TX | 1,205,255 | 4.80% | SC 13G/A · 14 Feb 2025 |
Anyone owning more than 5% must file a Schedule 13D (active) or 13G (passive). Structured filings since December 2024; a holder that drops below 5% files an exit amendment. 13F still covers them in the shareholding table.
| Settlement date | Short shares | Change | Days to cover | Relative size |
|---|---|---|---|---|
| 28 Nov 2025 | 2,105 | -99.2% | 1.00 | |
| 14 Nov 2025 | 262,352 | +249.2% | 1.00 | |
| 31 Oct 2025 | 75,122 | -28.3% | 1.00 | |
| 15 Oct 2025 | 104,743 | +1528.7% | 1.00 | |
| 30 Sep 2025 | 6,431 | -89.7% | 1.00 | |
| 15 Sep 2025 | 62,629 | +309.1% | 1.00 | |
| 29 Aug 2025 | 15,308 | -29.3% | 1.00 | |
| 15 Aug 2025 | 21,661 | -25.1% | 1.00 | |
| 31 Jul 2025 | 28,917 | +55.3% | 1.00 | |
| 15 Jul 2025 | 18,621 | -49.0% | 1.00 | |
| 30 Jun 2025 | 36,521 | +69.9% | 1.00 | |
| 13 Jun 2025 | 21,500 | +49.6% | 1.00 | |
| 30 May 2025 | 14,374 | -78.0% | 1.00 | |
| 15 May 2025 | 65,209 | -76.9% | 1.00 | |
| 30 Apr 2025 | 282,215 | +549.6% | 1.00 | |
| 15 Apr 2025 | 43,443 | +229.0% | 1.00 | |
| 31 Mar 2025 | 13,206 | -33.3% | 1.00 | |
| 14 Mar 2025 | 19,796 | -59.4% | 1.00 | |
| 28 Feb 2025 | 48,799 | +12.1% | 1.00 | |
| 14 Feb 2025 | 43,521 | -65.3% | 1.00 | |
| 31 Jan 2025 | 125,425 | -42.7% | 1.00 | |
| 15 Jan 2025 | 218,939 | +138.7% | 1.00 | |
| 31 Dec 2024 | 91,716 | -75.1% | 1.00 | |
| 13 Dec 2024 | 368,460 | +676.8% | 1.00 |
FINRA consolidated short interest, reported twice a month for every US listing.
Meihua International Medical Technologies Co Ltd의 SEC 공시 및 실적 발표 컨퍼런스콜 녹취록
What recent news says about Meihua International Medical Technologies Co Ltd, scored for sentiment.